Vijay Pratap Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vijay Pratap Singh has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Pushpendra Singh
Indian Council of Medical Research-National Institute of Research in Tribal Health, Jabalpur, India
3 shared publications - Jennifer L. Gerton
Stowers Institute for Medical Research, Kansas City, MO, USA
2 shared publications - Prashanth Suravajhala
Department of Biosciences, Manipal University Jaipur, India
2 shared publications - Shraddha Gurha
Model Rural Health Research Unit (MRHRU) Badoni Madhya Pradesh India
2 shared publications - A. Lalitha1 shared publication
- Abhishek Sengupta
Systems Biology and Data Analytics Research Laboratory, Centre for Computational Biology and Bioinformatics, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, India
1 shared publication
Latest Publications
- 20 May 2026
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (7) , 354-359
Monitoring Rubella Immunity and Transmission in Central India Amidst Elimination Efforts
India along with other countries in the World Health Organization (WHO) Southeast Asia region has set a goal to eliminate rubella by December 2026 through active tracking and vaccination program. However, the incidence of sporadic events and outbreaks in recent years has posed a significant challenge to this goal. To access the ongoing infections and the effectiveness of immunization efforts, we evaluated the presence of anti‐rubella IgM and IgG antibodies, which serve as indicators of ongoing infection and immune protection, respectively. Serum samples from individuals presenting with suspected rubella symptoms were collected and referred to the State Level Virus Research and Diagnostic Laboratory (SL‐VRDL) at ICMR‐NIRTH, Jabalpur between 1st May 2023 to 30th April 2024 for anti‐rubella IgM and IgG analysis. Concurrently, samples from healthy pregnant women, attending Netaji Subhash Chandra Bose Medical College & Hospital, Jabalpur were obtained during the same period to assess the prevalence of maternal immunity against rubella. Collected samples were tested for rubella specific IgM and IgG antibody using ELISA. Rubella IgM seropositivity rate during the study period was 7.2% across all age groups, indicating ongoing transmission of rubella in central India. Rubella IgG seropositivity, reflecting immunity, was 81.0%, among all age groups, demonstrating a high level of immunity against the rubella virus in this region. Among pregnant women, rubella IgG seropositivity was 89.6%, suggesting that most pregnant women of reproductive age are having protection against rubella infection. The finding indicates that rubella elimination efforts are on the right track, and that the vaccination program is broadly effective. However, continuous detection of IgM positive cases, particularly in young children, highlights, immunity gaps, that may hinder timely elimination. These gaps could be due to logistical, cultural, and educational barriers and require further intensive efforts towards active immunization. Targeted and intensified immunization efforts are essential to achieve the elimination goal by 2026.
- 20 May 2026
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (7) , 354-359
Monitoring Rubella Immunity and Transmission in Central India Amidst Elimination Efforts
India along with other countries in the World Health Organization (WHO) Southeast Asia region has set a goal to eliminate rubella by December 2026 through active tracking and vaccination program. However, the incidence of sporadic events and outbreaks in recent years has posed a significant challenge to this goal. To access the ongoing infections and the effectiveness of immunization efforts, we evaluated the presence of anti‐rubella IgM and IgG antibodies, which serve as indicators of ongoing infection and immune protection, respectively. Serum samples from individuals presenting with suspected rubella symptoms were collected and referred to the State Level Virus Research and Diagnostic Laboratory (SL‐VRDL) at ICMR‐NIRTH, Jabalpur between 1st May 2023 to 30th April 2024 for anti‐rubella IgM and IgG analysis. Concurrently, samples from healthy pregnant women, attending Netaji Subhash Chandra Bose Medical College & Hospital, Jabalpur were obtained during the same period to assess the prevalence of maternal immunity against rubella. Collected samples were tested for rubella specific IgM and IgG antibody using ELISA. Rubella IgM seropositivity rate during the study period was 7.2% across all age groups, indicating ongoing transmission of rubella in central India. Rubella IgG seropositivity, reflecting immunity, was 81.0%, among all age groups, demonstrating a high level of immunity against the rubella virus in this region. Among pregnant women, rubella IgG seropositivity was 89.6%, suggesting that most pregnant women of reproductive age are having protection against rubella infection. The finding indicates that rubella elimination efforts are on the right track, and that the vaccination program is broadly effective. However, continuous detection of IgM positive cases, particularly in young children, highlights, immunity gaps, that may hinder timely elimination. These gaps could be due to logistical, cultural, and educational barriers and require further intensive efforts towards active immunization. Targeted and intensified immunization efforts are essential to achieve the elimination goal by 2026.
- 6 November 2024
- Published by Taylor & Francis
- p. 43-59
Genomics and Transcriptomics in Reproductive Health
Reproductive health is an essential aspect of one’s total well-being, which includes the physical, emotional, and social aspects associated with the reproductive system. Despite its importance, it often lacks adequate attention in several communities, resulting in a range of challenges and illnesses. This chapter explores the many facets of reproductive health, analyzing both its social and clinical components. It explores the reproductive issues faced worldwide, such as ill-informed decision-making, infertility, pregnancy problems, sexually transmitted infections (STIs), abnormalities in menstruation, and related ailments. Moreover, this chapter explores the potential of genomics and transcriptomics techniques to tackle these gaps and challenges. Using advanced genetic and molecular methodologies, researchers and healthcare practitioners may acquire a more profound understanding of the intricacies of reproductive health. This thorough investigation highlights the need to comprehend reproductive health trends, recognize limitations, and formulate measures to improve reproductive well-being globally.
- 6 November 2024
- Published by Taylor & Francis
- p. 43-59
Genomics and Transcriptomics in Reproductive Health
Reproductive health is an essential aspect of one’s total well-being, which includes the physical, emotional, and social aspects associated with the reproductive system. Despite its importance, it often lacks adequate attention in several communities, resulting in a range of challenges and illnesses. This chapter explores the many facets of reproductive health, analyzing both its social and clinical components. It explores the reproductive issues faced worldwide, such as ill-informed decision-making, infertility, pregnancy problems, sexually transmitted infections (STIs), abnormalities in menstruation, and related ailments. Moreover, this chapter explores the potential of genomics and transcriptomics techniques to tackle these gaps and challenges. Using advanced genetic and molecular methodologies, researchers and healthcare practitioners may acquire a more profound understanding of the intricacies of reproductive health. This thorough investigation highlights the need to comprehend reproductive health trends, recognize limitations, and formulate measures to improve reproductive well-being globally.
- 6 November 2024
- Published by Taylor & Francis
- p. 128-145
Personalized Medicine in Reproductive Health
Personalized medicine is a concept that considers each patient’s genetic, epigenetic, metabolic, and lifestyle variables. Reproductive health services provide notable benefits in areas such as preventing, diagnosing, and treating infertility. Nevertheless, there is a substantial amount of work that must be accomplished. A detailed examination of the patient’s medical background, family history, and the results of prior assisted reproductive procedures can serve as the foundation for personalization. Genetic influences can be analyzed using large-scale population data and associations with reproductive health problems. Fertility, implantation, and live birth are influenced by various factors. In vitro fertilization (IVF) is expensive, emotionally challenging, and physically demanding. Screening for biomarkers, such as polycystic ovarian syndrome (PCOS), endometrial receptivity, and chromosomal abnormality genetic testing, can maximize the chance of a successful cycle. Personalized follow-up care is essential for women who become pregnant from assisted reproduction procedures. When counseling patients on infertility, it is important to consider the specific circumstances of each couple. Artificial intelligence (AI) and machine learning (ML) are revolutionizing personalized reproductive medicine, clinical decision-making, and image analysis, but their slow progress raises concerns about effectiveness, privacy, and bias. This chapter explores personalized medicine’s role in reproductive health, its potential benefits, and the challenges and limitations it has encountered in this emerging field.
- 6 November 2024
- Published by Taylor & Francis
- p. 128-145
Personalized Medicine in Reproductive Health
Personalized medicine is a concept that considers each patient’s genetic, epigenetic, metabolic, and lifestyle variables. Reproductive health services provide notable benefits in areas such as preventing, diagnosing, and treating infertility. Nevertheless, there is a substantial amount of work that must be accomplished. A detailed examination of the patient’s medical background, family history, and the results of prior assisted reproductive procedures can serve as the foundation for personalization. Genetic influences can be analyzed using large-scale population data and associations with reproductive health problems. Fertility, implantation, and live birth are influenced by various factors. In vitro fertilization (IVF) is expensive, emotionally challenging, and physically demanding. Screening for biomarkers, such as polycystic ovarian syndrome (PCOS), endometrial receptivity, and chromosomal abnormality genetic testing, can maximize the chance of a successful cycle. Personalized follow-up care is essential for women who become pregnant from assisted reproduction procedures. When counseling patients on infertility, it is important to consider the specific circumstances of each couple. Artificial intelligence (AI) and machine learning (ML) are revolutionizing personalized reproductive medicine, clinical decision-making, and image analysis, but their slow progress raises concerns about effectiveness, privacy, and bias. This chapter explores personalized medicine’s role in reproductive health, its potential benefits, and the challenges and limitations it has encountered in this emerging field.
- 1 September 2021
- Published by Elsevier in Fertility and Sterility
- Vol. 116 (3) , e412
TRANSCRIPTOMIC ANALYSIS REVEALS ALTERED GENE EXPRESSION IN MICE OOCYTES DURING THE PUBERAL TRANSITION
- 1 September 2021
- Published by Elsevier in Fertility and Sterility
- Vol. 116 (3) , e412
TRANSCRIPTOMIC ANALYSIS REVEALS ALTERED GENE EXPRESSION IN MICE OOCYTES DURING THE PUBERAL TRANSITION
- Open Access
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Persistent DNA Damage and Senescence in the Placenta Impacts Developmental Outcomes of Embryos
Cohesin is an evolutionarily conserved chromosome associated protein complex essential for chromosome segregation, gene expression and repair of induced DNA damage. Mutations that affect this complex cause the human developmental disorder Cornelia de Lange syndrome (CdLS), thought to arise from defective embryonic transcription. We establish a significant role for placental defects in the development of CdLS embryonic phenotypes using two mouse models (Nipbl and Hdac8). We show that placenta is a naturally senescent tissue and persistent DNA damage potentiates senescence and activates cytokine signaling. The negative impact of aggravated placental senescence on embryos is demonstrated by providing mutant embryos with a wildtype placenta, which significantly improves developmental outcomes. Genetically restricting cytokine signaling also improved mutant embryo outcomes. Our study highlights that cohesin is required for the repair of spontaneous DNA damage in placental cells. Furthermore, persistent DNA damage and ensuing placental senescence and cytokine production could underlie not only CdLS but represent a broad theme in embryo health and viability.
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Open AccessPersistent DNA Damage and Senescence in the Placenta Impacts Developmental Outcomes of Embryos
Cohesin is an evolutionarily conserved chromosome associated protein complex essential for chromosome segregation, gene expression and repair of induced DNA damage. Mutations that affect this complex cause the human developmental disorder Cornelia de Lange syndrome (CdLS), thought to arise from defective embryonic transcription. We establish a significant role for placental defects in the development of CdLS embryonic phenotypes using two mouse models (Nipbl and Hdac8). We show that placenta is a naturally senescent tissue and persistent DNA damage potentiates senescence and activates cytokine signaling. The negative impact of aggravated placental senescence on embryos is demonstrated by providing mutant embryos with a wildtype placenta, which significantly improves developmental outcomes. Genetically restricting cytokine signaling also improved mutant embryo outcomes. Our study highlights that cohesin is required for the repair of spontaneous DNA damage in placental cells. Furthermore, persistent DNA damage and ensuing placental senescence and cytokine production could underlie not only CdLS but represent a broad theme in embryo health and viability.